Prevalence of Anogenital Warts Among Participants in Private Health Plans in the United States, 2003–2010: Potential Impact of Human Papillomavirus Vaccination

Evidence of Human Papillomavirus Vaccine Effectiveness in Reducing Genital Warts: An Analysis of California Public Family Planning Administrative Claims Data, 2007–2010

(2012) Heidi M. Bauer et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Incidence of Genital Warts in Sweden Before and After Quadrivalent Human Papillomavirus Vaccine Availability

(2012) A. Leval et al.   JOURNAL OF INFECTIOUS DISEASES

Vaccine-Type Human Papillomavirus and Evidence of Herd Protection After Vaccine Introduction

(2012) J. A. Kahn et al.   PEDIATRICS

Increasing uptake of Gardasil among American adolescents: Comparisons with the history of Hepatitis B vaccination

(2011) Justin B. Dickerson et al.   Human vaccines & immunotherapeutics

Population Effectiveness, Not Efficacy, Should Decide Who Gets Vaccinated Against Human Papillomavirus via Publicly Funded Programs

(2011) P. E. Castle et al.   JOURNAL OF INFECTIOUS DISEASES

O5-S2.01 A National Program with a National impact: quadrivalent HPV vaccination and genital warts in Australia, 2004-2010

(2011) B. Donovan et al.   SEXUALLY TRANSMITTED INFECTIONS

The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme

(2011) T. R. H. Read et al.   SEXUALLY TRANSMITTED INFECTIONS

Gardasil: from bench, to bedside, to blunder

(2010) Peter B Bach   LANCET

Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007–2008

(2010) La'Shan D. Taylor et al.   PREVENTIVE MEDICINE

Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy

(2010) Julia M. L. Brotherton et al.   Sexual Health

What can surveillance of genital warts tell us?

(2010) Christopher K. Fairley et al.   Sexual Health

Post-licensure monitoring of HPV vaccine in the United States

(2010) Lauri E. Markowitz et al.   VACCINE

Approaches to monitoring biological outcomes for HPV vaccination: Challenges of early adopter countries

(2010) Charlene A. Wong et al.   VACCINE

Assessing incidence and economic burden of genital warts with data from a US commercially insured population

(2009) Tracey Hoy et al.   CURRENT MEDICAL RESEARCH AND OPINION

Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

(2009) Suzanne M. Garland et al.   JOURNAL OF INFECTIOUS DISEASES

Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women

(2009) C K Fairley et al.   SEXUALLY TRANSMITTED INFECTIONS

Monitoring the impact of vaccines postlicensure: new challenges, new opportunities

(2008) Anne Schuchat et al.   Expert Review of Vaccines

Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey—Adult 2007

(2008) Nidhi Jain et al.   PREVENTIVE MEDICINE

Partner Age Difference and Prevalence of Chlamydial Infection Among Young Adult Women

(2008) Cheryl R. Stein et al.   SEXUALLY TRANSMITTED DISEASES